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The surface M protein of group A streptococci is responsible for resistance of 
the  organism  to complement-mediated  opsonization  and  phagocytosis (1).  We 
have shown that  M  protein  on intact  streptococcal cells binds fibrinogen (2,  3) 
and that the bound fibrinogen prevents opsonization by complement in nonim- 
mune  human  blood  (2).  Bound  fibrinogen  also  inhibits  opsonization  by  low 
concentrations of anti-M antibody of the homologous serotype and can, in some 
cases, prevent opsonization  by heterologous crossreactive anti-M  sera (4).  The 
resistance  to  phagocytosis  of  M-positive  streptococci  suspended  in  serum  is 
intermediate  between  that  of organisms  suspended  in  plasma  and  organisms 
from  which  the  M  protein  has  been  removed  by trypsin  (2).  Accordingly,  we 
have concluded that binding of fibrinogen contributes to the antiopsonic activity 
of M protein in whole blood. 
The  present  investigation  was undertaken  to see if digested fibrinogen  and 
fibrin bind to M protein and, if so, whether they retain the antiopsonic properties 
of intact  fibrinogen.  This question arises because most streptococcal infections 
occur  in  tissue,  not  blood;  consequently,  the  organisms  might  be  exposed to 
degraded fibrinogen and fibrin rather than, or in addition to, intact fibrinogen, 
particularly since they elaborate a  plasminogen activator,  streptokinase (5).  We 
show that a highly purified peptide fragment of type 24 streptococcal M protein 
(pep  M24)  binds  to  the  D  region  of the  fibrinogen  molecule  (see  scheme  of 
fibrinogen degradation,  Fig.  1), including a  38 kD subfragment of fragment D, 
and that binding of D fragments to intact streptococcal cells is inhibited by pep 
M24.  The  binding affinity of the  various D  fragments  is on the average  ~30- 
fold lower than that of native fibrinogen; nonetheless, at physiologic concentra- 
tions,  digested  fibrinogen  retains  the  ability  to  block  complement-mediated 
opsonization  and  phagocytosis of streptococcal  cells.  Similarly,  digested  fibrin 
clot,  in which  the  D  fragments exist as crosslinked dimers,  is also antiopsonic. 
We conclude that digested fibrinogen and  fibrin bind to M protein on strepto- 
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FIC.URE  1.  Plasmic digestion  of fibrinogen (Fgn),  after reference 6.  Fibrinogen is a dimer 
composed of three pairs of polypeptide chains that join near their amino termini via extensive 
disulfide bridging, creating the central nodular domain. Nearer the carboxy termini,  the three 
chains on each side are extensively interconnected by disulfide bonds, creating the outer two 
nodular domains.  These disulfide  knot regions resist plasmic digestion.  Plasmin attacks  the 
extended chains,  creating fragments X,  Y, D, and E. All are heterogeneous, owing to the 
numerous points of plasmic attack on the molecule. 
coccal cells, and that this binding prevents effective opsonization and phagocytosis 
of the organisms. 
Materials  and  Methods 
Streptococci.  A  group A  strain of M serotype 24 (Vaughn) was blood-passed to a high 
level  of resistance  to  phagocytosis.  Cultures  were  stored  at  -80°C.  Organisms  were 
subcultured  to early log phase  in Todd-Hewitt broth  (Difco Laboratories,  Detroit,  MI) 
supplemented  with  20%  normal rabbit serum  (Gibco Laboratories,  Grand  Island,  NY), 
harvested by centrifugation, exposed to ultraviolet light for 3 min, washed in phosphate- 
buffered saline (PBS)',  (0.15  M  NaC1/0.02  M  phosphate,  pH  7.4),  and resuspended  in 
PBS at  10  TM colony-forming units (CFU)/ml. 
M  Protein.  A  polypeptide fragment  of type  24  M  protein  was extracted  by limited 
peptic  digestion  of whole  organisms  and  purified  by  ion  exchange  and  gel  filtration 
chromatography. The product, designated pep M24,  was judged to be pure by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (7). 
SH-Labeled and Unlabeled Fibrinogen (3).  Human fibrinogen (grade L, 90% clottable; 
KABI Diagnostica, Stockholm, Sweden) was dissolved in PBS at a concentration of 3.4 or 
13.6  mg clottable protein/ml  (10 or 40 #M),  dialyzed against PBS to remove salts,  and 
stored at -20°C.  For tritium labeling, fibrinogen was dissolved in 0.2 M sodium borate, 
pH 9.2, at a concentration of 10 #M, dialyzed against the same buffer, and subjected to 
reductive N-methylation at 4°C with 0.1 vol ofa 1% aqueous solution of [SH]formaldehyde 
(85  mCi/mmol;  New  England  Nuclear,  Boston,  MA),  followed by  0.3  vol  of sodium 
borohydride (12.8 mg/ml), according to the method of Rice and Means (8) as modified 
by Grinnell  (9).  The  product was  dialyzed against  PBS and  stored  at  -20°C.  Specific 
activity  was  1.8  Ci/mmol.  We  have  previously  shown  that  3H-fibrinogen  retains  the 
binding characteristics and antiopsonic properties of the unlabeled molecule (3). 
Plasmic Digests of Fibrinogen.  Fibrinogen,  10 or 40 #M in  PBS, was treated  with 0.1 
l Abbreviations used in this paper:  CFU, colony-forming units;  PBS, phosphate-buffered saline; 
SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis. WHITNACK AND  BEACHEY  1985 
U/ml plasmin (P-4895; Sigma Chemical Co., St. Louis, MO) at 37°C for the desired time 
interval, at which time digestion was stopped by addition of 0.8  mg/ml soybean trypsin 
inhibitor  (T-9003;  Sigma  Chemical  Co.).  For  overnight  digests,  trypsin  inhibitor  was 
added after 12-16 h incubation. Controls included pre-mixed plasmin and trypsin inhib- 
itor added  to  fibrinogen or  PBS.  Plasmic digestion  was carried out  in  the  absence of 
calcium to allow more extensive degradation of fragment D (see Discussion). 
Binding of  M Protein to Fibrinogen Degradation Products.  Fibrinogen digests were heated 
for 2 rain at 100°C in an equal volume of nonreducing sample buffer (0.6 M Tris/12% 
glycerol/l.2%  SDS/0.001%  brom phenol blue, pH 6.8).  Quadruplicate sets of samples 
were subjected to SDS-PAGE on four 7% acrylamide gels (10). The separated proteins 
on each gel were transferred to nitrocellulose paper (0.2 #m,  15  x  15 cm~; Schleicher 
and  Schuell,  Inc.,  Keene,  NH)  by  the  method  of Towbin  et  al.  (11).  The  resulting 
transblots were treated with the desired reagents, each treatment consisting of a 30 min 
soak in blocking buffer in the appropriate pH (0.01  M Tris/0.9%  NaCI/0.05% Tween- 
20/3%  bovine serum albumin),  followed by addition  of reagent to the buffer, further 
incubation at ambient temperature for 2 h, and finally, nine 5-min washes in  100 ml of 
0.01  M Tris/0.9%  NaCI/0.05%  Tween-20, pH 7.5.  Reagents included antisera diluted 
1:1000 at pH 7.5 and 0.2 I~M pep M24 at pH 5.0. Treatments of the four transblots were 
(a) peroxidase-labeled goat anti-human fibrinogen (Cappel Laboratories, Cooper Biomed- 
ical, Malvern, PA); (b) rabbit anti-fragment D (Diagnostica Stago, Asnieres, France), then 
peroxidase-labeled anti-rabbit Ig (Cappel Laboratories); (c) rabbit anti-fragment E (Diag- 
nostica Stago), then peroxidase-labeled anti-rabbit Ig (Cappel Laboratories); and (d) pep 
M24,  then  rabbit  anti-pep  M24  (7),  then  peroxidase-labeled  anti-rabbit  Ig  (Cappel 
Laboratories). The treated transblots were developed by incubation in  100 ml of 0.02 M 
Tris/2.9%  NaCI, pH 7.5, to which were added  200 #1 of 30%  hydrogen peroxide and 
120  mg of horseradish  peroxidase color development reagent  (Bio-Rad  Laboratories, 
Richmond, CA) dissolved in 40 ml cold (-20°C) methanol. 
Binding of Fibrinogen  and Fibrin(ogen) Degradation  Products to Streptococcal Cells.  In 
experiments in which digests of fibrin or fibrinogen were used to inhibit the binding of 
3H-fibrinogen to streptococcal cells,  assay mixtures consisted of 20  nM  3H-fibrinogen, 
serial dilutions of inhibitor, 0.1% Tween-20, and 3 x  108 CFU streptococci (added last) 
in a total volume of 200 #l PBS. After 45 rain incubation at ambient temperature, binding 
was measured by counting 80 tzl of each assay mixture and 80 ~I of each supernatant to 
determine percentage of counts bound (3).  For experiments in which pep M24 was used 
to inhibit the binding of digested 3H-fibrinogen, washed pellets were counted rather than 
mixtures  and  supernatants,  because  of the  lower  binding  affinity  of  the  fibrinogen 
fragments. Assay mixtures consisted of an overnight digest of 0.7 #M ~H-fibrinogen, 0.1% 
Tween-20, and serial dilutions of pep M24 in a total volume of 170 #1 PBS. After 45 min 
preincubation  at ambient  temperature,  3  x  108  CFU  streptococci in  30  #1  PBS  were 
added and the mixture further incubated for 45 min. Pellets were washed three times in 
1.25 ml PBS/0.1% Tween-20. For counting, samples were placed in vials containing 0.5 
ml PBS/0.1%  Tween-20 and  1 mg pronase (Protease Type XIV; Sigma Chemical Co.), 
incubated at  37°C  for  1 h,  mixed with  10  ml Hydrofluor (National  Diagnostics,  Inc., 
Somerville, N  J) and counted in a Packard Tricarb 460C liquid scintillation counter (3). 
To determine the effect of pH on the binding of 20 nM SH-fibrinogen to streptococcal 
cells,  assays were performed as described above, except that the following buffers were 
substituted for PBS:  0.08 M citrate, pH 2.82-5.34;  0.8 M citrate and 0.16 M phosphate 
in varying ratios to yield pH 5.46-6.56;  0.16 M phosphate, pH 5.91-7.57;  0.16 M Tris, 
pH 7.11-8.97; and 0.16 M glycine, pH 8.85-9.91.  Phosphate buffer, 0.2 M at pH 7.0- 
7.6, was used in the counting vials in place of PBS to neutralize the samples before pronase 
digestion. 
Electron Microscopy.  Streptococci (3 ×  108 CFU) were treated with 10 #M fibrinogen, 
digested I0 #M fibrinogen, or control buffer for 20 rain at ambient temperature, washed 
three times in PBS/0.1% Tween-20, fixed in 2.5% glutaraldehyde/0.1% sodium cacodyl- 
ate at pH 7.2,  postfixed in osmium tetroxide, dehydrated in alcohol, and embedded in 
Spurr's medium for transmission electron microscopy (12). 1986  FIBRIN(OGEN) D  FRAGMENTS AND  STREPTOCOCCAL  M  PROTEIN 
Detection of Bound Complement (C3) by Immunofluorescence Microscopy.  Streptococci (3 X 
108 CFU)  were treated for 30  rain  at  37°C with  35% fresh human  serum and either 
digested 4.4 #M fibrinogen, serial  10-fold dilutions of 4.4 #M undigested fibrinogen, or 
blank containing plasmin and trypsin inhibitor. The cells were washed three times in PBS 
and  incubated  for  30  rain  at  ambient  temperature  in  100  #1  of a  1:160  dilution  of 
fluorescein-labeled anti-human C3 (Cappel Laboratories). The treated cells were again 
washed three times, smeared on glass slides, embedded in 20% polyvinyl alcohol (Gelvatol; 
Monsanto Co., St.  Louis, MO) in 0.01  M phosphate at pH 7.2, and examined under oil 
immersion with a fluorescence microscope (2). 
Opsonophagocytic and Bactericidal Tests.  Normal volunteers were selected who lacked 
antibody to type 24  M  protein as determined by enzyme-linked immunosorbent assay 
(reciprocal titers,  <200)  and  by opsonophagocytic tests  using whole  blood and  blood 
reconstituted from serum and washed cells. Serum, plasma, and blood cells were obtained 
as described previously (4). Opsonophagocytic test mixtures (470 •l)  consisted of 200 #1 
serum or plasma,  !.6 U heparin, 150 ul washed blood cells (erythrocytes and buff~ coat), 
100  #1  test fluid, and,  finally, 20  tA  of streptococcal suspension  containing  10  ~ CFU. 
Mixtures were incubated with rotation at 37°C. Small samples (20 ~1) were removed at 
45  rain,  smeared on glass  slides,  stained with  Wright's stain, and examined under oil 
immersion.  100 neutrophils were counted, and the percentage with associated bacteria 
was noted. Bactericidal tests were performed similarly, except that live cultures were used, 
the inoculum was reduced by dilution to <200 CFU, and incubation was carried out for 
3 h. Inocula and surviving organisms were counted by pour plates. 
Degradation Products of Crosslinked Fibrin.  Crosslinked  fibrin degradation products 
were prepared by a standard clinical  method for euglobulin clot lysis time (13) in which 
plasma is anticoagulated by decalcification with 0.01 M sodium citrate, then precipitated 
in 19 vol of 0.014% acetic acid to remove plasmin inhibitors, redissolved in 1 vol of 0.01 
M borate/0.9% NaCI at pH 9.0, and recalcified by addition of 1 vol 0.025 M CaClz. Upon 
recalcification, the fraction clots within a few minutes. The clot is spontaneously digested 
by the plasmin in the fraction upon further incubation at 37°C for 1-3 h. In the present 
study, crosslinking of the clot was confirmed by insolubility in 5 M urea at 37 °C for 24 h 
(14) and by SDS-PAGE (see  Results).  Digestion was allowed to proceed for 12 h  after 
disappearance of the clot, at which time  1 mg/ml soybean trypsin inhibitor was added. 
Controls included unrecalcified plasma, citrated serum, and unrecalcified plasma to which 
soybean trypsin inhibitor was added at the outset to prevent digestion. All fractions were 
dialyzed against PBS before use. 
Results 
In our previous studies (3, 4), we presented evidence that the surface M protein 
of  the  streptococcal  cell  is  a  high-affinity  binding  site  for  fibrinogen.  This 
evidence includes (a) precipitation  of fibrinogen  by a  highly purified  33.5  kD 
fragment  of type  24  M  protein  (pep  M24);  (b)  dose-dependent  inhibition  of 
binding  of fibrinogen  to  streptococcal  cells  by  this  peptide;  (c)  inhibition  of 
binding of anti-M antibody to streptococci by fibrinogen and vice versa; and (d) 
prevention of fibrinogen binding by a gentle proteolytic treatment of the strep- 
tococcal cells that removes the M protein but leaves the surface fibrillae partially 
intact.  Accordingly,  we  wished  to  see  if  pep  M24  reacted  with  fibrinogen 
degradation products. 
Reaction of Fibrinogen Degradation Products with a Polypeptide Fragment of Type 
24 M Protein (Pep M24).  Timed fibrinogen digests were subjected to SDS-PAGE 
and  transferred to  nitrocellulose paper  by electroblotting.  One  such  transblot 
was developed with peroxidase-labeled antifibrinogen.  To determine the origin 
of the fragments within  the intact molecule, two other transblots were treated WHITNACK  AND  BEACHEY  1987 
with anti-D and anti-E sera, these two regions of the fibrinogen molecule being 
immunologically distinct  (15).  These  transblots  were  compared  with  a  fourth 
transblot treated with pep M24. The results (Fig.  2) show that pep M24 reacts 
with all species that bind anti-D antibody, including several closely spaced bands 
at 38 kD designated  D", but not with fragments reacting only with anti-E.  Pep 
M24 failed to bind to individual polypeptide chains of fibrinogen and its deriv- 
atives  when  reacted  with  transblots  of the  same-timed  digests  reduced  with 
mercaptoethanol before electrophoresis. 
Binding of Fibrinogen Degradation Products  to Intact Streptococcal Cells.  We 
next sought to determine whether fibrinogen degradation products would bind 
to  M  protein  on  intact streptococcal cells.  Type 24  cells were treated with  an 
overnight plasmic digest of fibrinogen containing D and E  fragments. The cells 
absorbed  the  same  D-related  fragments  as  had  reacted with  pep  M24  (Fig.  3; 
FIGURE 2.  Transblots of timed digests of fibrinogen (Fgn), reacted with (A) antifibrinogen; 
(B) a polypeptide fragment of type 24 streptococcal M protein (pep M24); (C) anti-fragment 
E, which reacts with species containing the central nodular domain; and (D) anti-fragment D, 
which reacts with species containing one or both outer nodular domains. Pep M24 reacts with 
the same species as anti-D, but not with species reacting only with anti-E. 1988  FIBRIN(OGEN)  D  FRAGMENTS  AND  STREPTOCOCCAL  M  PROTEIN 
FICURE 3.  SDS-PAGE of an overnight plasmic digest of fibrinogen. (1) Unabsorbed digest; 
(2) digest absorbed with type 24 streptococci that have been treated with trypsin (1  mg/ml in 
PBS for 30 rnin at 37 °C) to remove the M protein-bearing surface fibrillae; (3) digest absorbed 
with untreated type 24 streptococci. 
compare Fig.  2).  Similarly, plasmin treatment of fibrinogen-coated streptococci 
released fragment E  but not the D fragments.  In transmission electron micro- 
graphs,  the  cells  treated with  digested  fibrinogen showed the same increased 
density of the M protein-bearing fibrillar layer as cells treated with undigested 
fibrinogen (Fig. 4). 
To confirm that the D fragments bind to the same site on the bacterial cells as 
does intact fibrinogen, an overnight plasmic digest was used to inhibit the binding 
of 3H-fibrinogen to type 24 streptococci. Complete inhibition was obtained (Fig. 
5).  When a  single concentration of digested fibrinogen was used to inhibit the 
binding of ~H-fibrinogen at  a  range of concentrations, a  parallel  shift  in  the 
binding isotherm was obtained. Assuming two inhibitory fragments per fibrino- 
gen molecule, the data (Fig. 5) indicate that the average affinity of the fragments 
(inhibitory constant,  100  nM) is ~30-fold  lower than  that of intact fibrinogen 
(dissociation constant, 3 nM). To further confirm the role of M protein in the 
binding of D fragments to intact cells, pep M24 was used to inhibit the binding 
of digested  3H-fibrinogen.  Concentration-dependent  inhibition  was  obtained 
(Fig. 6). 
Inhibition of Opsonization and Phagocytosis of Streptococci by Fibrinogen Degrada- 
tion Products.  Having found that D fragments, like fibrinogen, bind to M protein 
on streptococcal cells, we next wanted to see if the bound fragments retained 
the ability to prevent opsonization by complement and, therefore, phagocytosis WH1TNACK  AND  BEACHEY  1989 
FIGURE 4.  Electron micrographs of type 24 streptococci treated with (A) control buffer; (B) 
undigested  fibrinogen;  (C)  an  overnight  plasmic digest  of fibrinogen  as  shown  in  Fig.  3. 
Original magnification: × 60,000. 
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FIGURE 5.  Concentration-dependent  inhibition  of the binding of 20  nM  SH-fibrinogen  to 
type 24 streptococci by an overnight plasmic digest of 4.8 ttM  unlabeled fibrinogen serially 
diluted as shown. 
by neutrophils.  Streptococci  were  treated  with  fresh  nonimmune  human  serum 
containing  an overnight  plasmic digest of 4.4  gM fibrinogen,  undigested  4.4  pM 
fibrinogen  diluted  10 °  to  10 -2,  or  control  buffer.  All  test  mixtures  contained 
equal  quantities  of plasmin  and  soybean  trypsin  inhibitor.  Treated  cells  were 1990  FIBRIN(OGEN)  D  FRAGMENTS  AND  STREPTOCOCCAL  M  PROTEIN 
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FIGURE 6.  Concentration-dependent inhibition of the binding of digested 0.7 t~M 3H-fibrin- 
ogen to type 24 streptococci by pep M24 (O). In a control series, streptococci were omitted to 
rule out precipitation  of the labeled fragments  by the pep M24 (O). 
washed and stained with fluorescein-labeled anti-C3. As in previous studies (2), 
control cells stained brightly and evenly, whereas cells treated with 4.4 or 0.44 
#M fibrinogen did not fluoresce. Cells treated with digested fibrinogen fluoresced 
dimly and unevenly (Fig.  7).  A  similar uneven fluorescence was obtained with 
fibrinogen diluted 100-fold (not shown). 
To determine the extent to which this inhibition of complement deposition 
impairs  phagocytosis  by  neutrophils,  streptococci  were  incubated  with  fresh 
serum,  washed blood  cells,  and  threefold dilutions  of digested or  undigested 
fibrinogen. Neutrophils were scored for associated bacteria. Digested fibrinogen 
proved to be ~50 times less potent as an inhibitor (assuming two active fragments 
per fibrinogen molecule), but  at  concentrations >1  #M  before digestion,  the 
fragments  were  fully  effective  in  preventing  recognition  of the  bacteria  by 
neutrophils (Fig. 8). This result was confirmed with a bactericidal test (Table I). 
Degradation Products of Crosslinked Fibrin.  In the formation of a  fibrin clot, 
fibrin monomer (which differs from fibrinogen in  the absence of two pairs of 
small peptides from the central E region) first polymerizes via noncovalent (or 
very  weak  covalent)  interactions  between  the  D  and  E  regions  of adjacent 
molecules,  after  which  covalent  crosslinks  are  formed  enzymatically in  the 
presence of calcium between the gamma and alpha chains of the D domains (16). 
The gamma-gamma crosslinks resist plasmic degradation; consequently, dimers 
of fragment D are formed in the process of digestion. These dimers are nonco- 
valently complexed with  fragment E as  in  the intact fibrin polymer (17).  We 
prepared digests of crosslinked fibrin from plasma using a  standard technique 
for euglobulin  clot  lysis  (see  Materials  and  and  Methods).  Controls  included 
unrecalcified plasma (to prevent crosslinking), unrecalcified plasma treated with 
soybean  trypsin  inhibitor  to  prevent  digestion,  and  serum.  The  presence  of WHITNACK  AND  BEACHEY  1991 
FIGURE  7.  Staining of streptococcal  cells with  fluorescein-labeled anti-CS  after  treatment 
with fresh human serum and (A) control buffer; (B) undigested fibrinogen; or (C) an overnight 
plasmic digest of fibrinogen. 
dimeric  D,  monomeric  D,  and  undigested  fibrin(ogen)  in  the  three  plasma 
fractions was confirmed by SDS-PAGE (Fig. 9) and by immunoblotting with anti° 
D serum. 
In each case,  the  D-containing species present could be  absorbed  by intact 
streptococcal  cells  and  eluted  with  SDS  (Fig.  9),  and  each  plasma  fraction 
inhibited  binding  of 3H-fibrinogen  to  streptococcal  cells  (Fig.  10).  In  these 
experiments  the  "~H-fibrinogen,  the  inhibitor,  and  the  cells  were  incubated 
together (see Materials and  Methods). Inhibition by the crosslinked digest was 
virtually identical  when  tested by pretreating  the cells with serial dilutions  of 
digest, washing them, and then exposing them to 20 nM 3H-fibrinogen. All the 
plasma fractions inhibited opsonization (Fig.  11),  but the crosslinked digest was 
consistently less effective than the noncrosslinked digest or the undigested plasma 
fraction. The reason for this was unclear, but was not due to any intrinsic opsonic 
activity in the preparation, since no uptake of bacteria could be obtained when 
heat-inactivated serum was substituted for fresh serum in the phagocytosis test 1992  FIBRIN(OGEN)  D  FRAGMENTS  AND  STREPTOCOCCAL  M  PROTEIN 
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FIC.URE 8.  Uptake  of type 24  streptococci by neutrophils  suspended  in fresh  serum  and 
dilutions of 10/~M fibrinogen  (0) or an overnight  plasmic digest of 10 pM fibrinogen  (O). 
Controls included PBS (A) and a blank containing plasmin and soybean trypsin inhibitor (A) 
as in the undiluted fibrinogen and digest samples. 
TABLE  I 
Effect of Plasmin-digested Fibrinogen on Killing of Type 24 
Streptococci by Leukocytes and Serum 
Inoculum* 
Number of colonies after 3 h incubation with blood 
cells and serum plus: 
Blank,  Digest of 10 uM  10 pM 
fibrinogen  fibrinogen 
8  0  3,548  875 
20  77  5,489  2,640 
63  143  19,140  15,180 
157  630  42,570  28,710 
* Pour-plate counts of 100 ~[ of each culture dilution. 
* PBS containing plasmin and soybean trypsin inhibitor as in the digested 
and undigested fibrinogen preparations. 
mixtures;  furthermore,  the  crosslinked  digest  inhibited  binding  of C3  slightly 
less  than  did  the  noncrosslinked  digest  in  immunofluorescence  studies  (not 
shown).  In  control  experiments,  none  of the  fractions  had  any  effect  on  the 
uptake by neutrophils of an avirulent, M-negative strain (D58X). 
Effect  of pH  on  Binding  of "~H-Fibrinogen to  Streptococcal  Cells.  The  p]-I  of 
inflammatory exudates  may be  lower  than  that  of blood;  values as low  as  5.6 
have been reported (see reference  18).  In a  final experiment, we measured the 
binding of ~H-fibrinogen to type 24 streptococci in overlapping buffer systems 
over the pH range 2.8-10.  Binding was maximal between pH 4 and 6  (Fig.  12), 
falling off substantially below pH 3.8.  Binding would, therefore, be expected to 
occur at the pH levels encountered  in vivo. WHITNACK  AND  BEACHEY  1993 
FIGURE 9.  SDS-PAGE on 6% polyacrylamide gels under nonreducing conditions. (Left, lane 
1)  An  overnight plasmic  digest  of fibrinogen (Fgn); (2)  autodigest  of recalcified plasma 
euglobulin  (crosslinked fibrin clot) containing  D dimers; (3) autodigest of nonrecalcified  plasma 
euglobulin  (noncrosslinked fibrin or fibrinogen)  containing  D monomers; (4) serum euglobulin 
fraction; (5) nonrecalcified plasma euglobulin to which soybean trypsin inhibitor was added to 
prevent digestion. (Right) The same fractions after elution from type 24 streptococcal cells 
with SDS (corresponding lane numbers). 
Discussion 
In this study, we have shown that group A  streptococci bind the D  family of 
fibrinogen and  fibrin  degradation  products,  i.e., the fragments containing the 
outer nodular domain of the fibrinogen molecule. This finding is in accord with 
the previously reported  observation  of Runehagen et ai.  (19)  who found that 
125I-labeled X, Y, and D  fragments bound to various group A  strains.  We have 
previously shown that the binding site for intact fibrinogen is M protein (3). This 
appears  to  hold  true  for  the  degradation  products  also,  since  (a)  purified  M 
protein (pep M24) reacts with the same fragments as bind to the intact strepto- 
coccal cells; (b) pep M24 inhibit the binding of digested fibrinogen to the cells; 
and (c) digested fibrinogen competitively inhibit the binding of intact fibrinogen. 
The  binding affinity  of D  fragments  averages  ~30-fold  lower  than  that  of 
fibrinogen, and digested fibrinogen digest is -50  times less potent in blocking 
uptake of streptococci by neutrophiis.  Despite their lower binding affinity and 
proportionately  lower  antiopsonic  potency,  fibrinogen  degradation  products 
completely inhibit phagocytosis at concentrations >1  I~M. The concentration of 
fibrinogen in blood is normally ~10 uM and may increase two- to threefold in 
inflammatory  states  (20).  Provided  that  vascular  permeability  increased  suffi- 
ciently at the site of inflammation to allow free passage of fibrinogen into the 1994  FIBRIN(OGEN)  D  FRAGMENTS  AND  STREPTOCOCCAL  M  PROTEIN 
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FIGURE 10.  Inhibition of binding of 20 nM ~H-fibrinogen to type 24 streptococcal cells by 
the fi'actions shown in Fig. 9: digested fibrin clot (0); digested noncrosslinked fibrin(ogen) (©); 
undigested noncrosslinked fibrin(ogen) (,ix); and serum (V1). The concentration of the undiluted 
inhibitors was nominally one-fourth that of whole plasma. 
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of  uptake  by  neutrophils  (PMN)  of type  24  streptococci  by  the 
fractions  shown  in  Fig,  9:  digested  crosslinked  fibrin  clot (I--1); digested  noncrosslinked  fi- 
brin(ogen) (0); undigested noncrosslinked fibrin(ogen) (11); and serum (A). 
extracellular space, the concentration of fibrinogen and its degradation products 
would be sufficient to block opsonization even if degradation of fibrinogen were 
complete. 
We prepared fibrinogen degradation products in  the absence of calcium so 
that D fragments smaller than D1  would be generated (21), permitting certain 
preliminary conclusions about the M protein-binding site on fibrinogen. Frag- 
ment D3 differs from D 1 in the loss of a segment of the carboxy terminus of the 
gamma chain. This segment contains several functional sites, including a fibrin 
polymerization  site,  two  sites  for  covalent  gamma-gamma  crosslinking,  and 
binding  sites for platelet fibrinogen receptor, staphylococcal clumping factor, 
and ionized calcium (see reference 22). The M protein-binding site is retained WHITNACK AND BEACHEY  1995 
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FIGURE 12.  Binding  of 20 nM ~H-fibrinogen  to type 24 streptococci  as a function of pH. 
Buffer  systems  were citrate (O), citrate-phosphate  (O), phosphate  (A), Tris (n), and glycine  ([2]). 
on fragment D3 and would, therefore, appear to differ from these sites. We have 
investigated the effect of calcium (~10 mM), EDTA (~0.6 raM), and EGTA (10 
mM) on binding of 3H-fibrinogen to type 24 streptococci; all were without effect 
(unpublished observation). 
An incidental observation of this study reproduces an earlier finding of  Jacks- 
Weis  and  colleagues (23),  namely that  complement deposited  in  the  uneven 
pattern shown in Fig.  7 does not promote phagocytosis by neutrophils. In that 
study,  the  pattern  was  obtained  using  serum  without  added  fibrinogen  or 
fibrinogen degradation products. These investigators proposed that the uneven 
distribution  of the  bound  complement prevented  efficient enclosure  of the 
bacterial cells in a phagosome by the "zipper" mechanism of Griffin et al. (24). 
We have noticed (2) that even when complement is deposited evenly over the 
entire surface of M-positive streptococci, the bacteria remain somewhat more 
resistant  to  phagocytosis than  M-negative cells.  We  suspect  that  complement 
deposited on the cell wall is partially inaccessible to receptors on the leukocyte 
because of hindrance by the projecting surface fibrillae. 
In conclusion, fibrin and fibrinogen degradation products of the D family bind 
to M protein on group A streptococci, and, like fibrinogen, block complement- 
mediated opsonization and phagocytosis in the absence of anti-M antibody. This 
process may be relevant to circumstances in which fibrin(ogen)olysis is occurring, 
such as inflammatory exudation in tissue infections. 
Summary 
The biological effects of the binding of fibrin(ogen) degradation products to 
M protein-bearing group A  streptococci were investigated. Type 24  group A 
streptococci bind  fibrinogen  degradation  products  of the  D  family,  but  not 
fragment E. Binding appears to be mediated by M protein, since a large peptide 
of this molecule (pep M24) bound to fragments containing the terminal domains 
of the fibrinogen molecule (D,  X,  and Y),  but  not fragment E, and pep  M24 
inhibited the binding of digested fibrinogen to streptococcal cells. An M protein- 
binding site occurs on fragment D3 and, therefore, differs from several functional 
sites present on D1 but not D3, including the fibrin polymerization site, the two 1996  FIBRIN(OGEN) D FRAGMENTS AND  STREPTOCOCCAL M PROTEIN 
3'  chain crosslink  sites,  and  the  binding  sites  for platelet  fibrinogen receptor, 
staphylococcal clumping factor, and ionized calcium. Bound fibrinogen degra- 
dation products  prevented  deposition of C3  on  the  streptococcal  cell  surface, 
and,  in  consequence,  prevented  phagocytosis  by  neutrophils  in  nonimmune 
blood. The average affinity of D fragments for the streptococcal cell surface was 
~30  times lower than that of native fibrinogen, and a  terminal plasmic digest 
was ~50 times less potent in inhibiting opsonization by C3. However, physiologic 
concentrations of digested fibrinogen sufficed to inhibit opsonization and phag- 
ocytosis completely. Digests of crosslinked fibrin clot also inhibited opsonization, 
although slightly less  effectively than did fibrinogen digests.  The  antiopsonic 
effect of fibrin(ogen) degradation products may be relevant to circumstances in 
which fibrin(ogen)olysis is occurring, e.g., exudation and suppuration. 
We thank Dr. Carolyn Chesney of the Division of Hematology for helpful suggestions; 
Gina Ayerdis, Loretta Hatmaker, Edna Chiang, and Dan Monroe for excellent technical 
assistance; and Connie Carrier for excellent secretarial assistance  in preparing the manu- 
script. 
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